These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 33348781)
1. B7-H3 Chimeric Antigen Receptor Redirected T Cells Target Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma. Zi Z; Zhao H; Wang H; Ma X; Wei F Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33348781 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of B7-H3-Redirected BiTE and CAR-T Immunotherapies Against Extranodal Nasal Natural Killer/T Cell Lymphoma. Zheng M; Yu L; Hu J; Zhang Z; Wang H; Lu D; Tang X; Huang J; Zhong K; Wang Z; Li Y; Guo G; Liu S; Tong A; Yang H Transl Oncol; 2020 May; 13(5):100770. PubMed ID: 32298986 [TBL] [Abstract][Full Text] [Related]
3. Case report: Differential diagnosis of highly amplified anti-CD5 CAR T cells and relapsed lymphoma cells in a patient with refractory ALK positive anaplastic large cell lymphoma. Mu W; Zhang M; Hu G; Han Y; Mao X; Chen C; Shen K; Dai Z; Zhu X; Zhou X; Huang L; Ao Q; Xiao M Front Immunol; 2023; 14():1280007. PubMed ID: 38143760 [TBL] [Abstract][Full Text] [Related]
4. Bioactivity and safety of B7-H3-targeted chimeric antigen receptor T cells against anaplastic meningioma. Tang X; Liu F; Liu Z; Cao Y; Zhang Z; Wang Y; Huang J; Fan S; Zhao S; Chen Y; Li G; Wang S; Zheng M; Hu Y; Li H; Jiang C; Yang M; Yang H; Xu J; Guo G; Tong A; Zhou L Clin Transl Immunology; 2020; 9(6):e1137. PubMed ID: 32547742 [TBL] [Abstract][Full Text] [Related]
5. A novel anti-B7-H3 chimeric antigen receptor from a single-chain antibody library for immunotherapy of solid cancers. Birley K; Leboreiro-Babe C; Rota EM; Buschhaus M; Gavriil A; Vitali A; Alonso-Ferrero M; Hopwood L; Parienti L; Ferry G; Flutter B; Himoudi N; Chester K; Anderson J Mol Ther Oncolytics; 2022 Sep; 26():429-443. PubMed ID: 36159778 [TBL] [Abstract][Full Text] [Related]
6. Cell-surface antigen profiling of pediatric brain tumors: B7-H3 is consistently expressed and can be targeted via local or systemic CAR T-cell delivery. Haydar D; Houke H; Chiang J; Yi Z; Odé Z; Caldwell K; Zhu X; Mercer KS; Stripay JL; Shaw TI; Vogel P; DeRenzo C; Baker SJ; Roussel MF; Gottschalk S; Krenciute G Neuro Oncol; 2021 Jun; 23(6):999-1011. PubMed ID: 33320196 [TBL] [Abstract][Full Text] [Related]
7. Synergistic Effect of Alectinib and Everolimus on ALK-positive Anaplastic Large Cell Lymphoma Growth Inhibition. Kim D; Koh Y; Yoon SS Anticancer Res; 2020 Mar; 40(3):1395-1403. PubMed ID: 32132036 [TBL] [Abstract][Full Text] [Related]
8. B7-H3-Targeted CAR-T Cells Exhibit Potent Antitumor Effects on Hematologic and Solid Tumors. Zhang Z; Jiang C; Liu Z; Yang M; Tang X; Wang Y; Zheng M; Huang J; Zhong K; Zhao S; Tang M; Zhou T; Yang H; Guo G; Zhou L; Xu J; Tong A Mol Ther Oncolytics; 2020 Jun; 17():180-189. PubMed ID: 32346608 [TBL] [Abstract][Full Text] [Related]
9. A novel microenvironment regulated system CAR-T (MRS.CAR-T) for immunotherapeutic treatment of esophageal squamous carcinoma. Wang L; Wang X; Wu Y; Wang J; Zhou W; Wang J; Guo H; Zhang N; Zhang L; Hu X; Zhao Y; Miao J; Zhang Z; Chard Dunmall LS; Zhang D; Lemoine NR; Cheng Z; Wang Y Cancer Lett; 2023 Aug; 568():216303. PubMed ID: 37422126 [TBL] [Abstract][Full Text] [Related]
10. A high-content screen of FDA approved drugs to enhance CAR T cell function: ingenol-3-angelate improves B7-H3-CAR T cell activity by upregulating B7-H3 on the target cell surface via PKCα activation. Lee HW; O'Reilly C; Beckett AN; Currier DG; Chen T; DeRenzo C J Exp Clin Cancer Res; 2024 Apr; 43(1):97. PubMed ID: 38561833 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of tyrosine kinase activity induces caspase-dependent apoptosis in anaplastic large cell lymphoma with NPM-ALK (p80) fusion protein. Ergin M; Denning MF; Izban KF; Amin HM; Martinez RL; Saeed S; Alkan S Exp Hematol; 2001 Sep; 29(9):1082-90. PubMed ID: 11532349 [TBL] [Abstract][Full Text] [Related]
12. B7-H3-targeted CAR-T cell therapy for solid tumors. Li G; Wang H; Wu H; Chen J Int Rev Immunol; 2022; 41(6):625-637. PubMed ID: 35855615 [TBL] [Abstract][Full Text] [Related]
13. Targeting Radiation-Resistant Prostate Cancer Stem Cells by B7-H3 CAR T Cells. Zhang Y; He L; Sadagopan A; Ma T; Dotti G; Wang Y; Zheng H; Gao X; Wang D; DeLeo AB; Fan S; Sun R; Yu L; Zhang L; Wang G; Ferrone S; Wang X Mol Cancer Ther; 2021 Mar; 20(3):577-588. PubMed ID: 33653946 [TBL] [Abstract][Full Text] [Related]
15. ALCL by any other name: the many facets of anaplastic large cell lymphoma. Irshaid L; Xu ML Pathology; 2020 Jan; 52(1):100-110. PubMed ID: 31706671 [TBL] [Abstract][Full Text] [Related]
16. B7-H3 as a Target for CAR-T Cell Therapy in Skull Base Chordoma. Long C; Li G; Zhang C; Jiang T; Li Y; Duan X; Zhong G Front Oncol; 2021; 11():659662. PubMed ID: 34868903 [TBL] [Abstract][Full Text] [Related]
18. Switchable CAR T cell strategy against osteosarcoma. Hidalgo L; Somovilla-Crespo B; Garcia-Rodriguez P; Morales-Molina A; Rodriguez-Milla MA; Garcia-Castro J Cancer Immunol Immunother; 2023 Aug; 72(8):2623-2633. PubMed ID: 37062034 [TBL] [Abstract][Full Text] [Related]
19. B7-H3 targeted CAR-T cells show highly efficient anti-tumor function against osteosarcoma both in vitro and in vivo. Zhang Q; Zhang Z; Liu G; Li D; Gu Z; Zhang L; Pan Y; Cui X; Wang L; Liu G; Tian X; Zhang Z BMC Cancer; 2022 Nov; 22(1):1124. PubMed ID: 36320072 [TBL] [Abstract][Full Text] [Related]
20. Signal transducer and activator of transcription-3 activation contributes to high tissue inhibitor of metalloproteinase-1 expression in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma. Lai R; Rassidakis GZ; Medeiros LJ; Ramdas L; Goy AH; Cutler C; Fujio Y; Kunisada K; Amin HM; Gilles F Am J Pathol; 2004 Jun; 164(6):2251-8. PubMed ID: 15161657 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]